Mometason Glenmark (Mometasone Furoate)

Mometasone furoate binds to glucocorticoid receptors inside skin cells. The resulting complex alters gene transcription, suppressing the production of inflammatory cytokines, chemokines and adhesion molecules. This reduces leukocyte migration and vascular permeability, leading to a marked decrease in local inflammation and immune response.

The dosage of Mometason Glenmark is determined by the prescribing healthcare professional based on the severity of the skin condition, the area to be treated and patient age. The prescriber will provide specific instructions on the amount to apply, frequency and duration of therapy.

The pregnancy safety category for mometasone furoate is not definitively established. Because systemic absorption can occur, especially with extensive or prolonged use, the drug should only be used during pregnancy or lactation if the potential benefit outweighs the possible risk. Consultation with a physician is essential.

To place an order, visit the product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Mometasone furoate is considered a high‑potency topical corticosteroid, similar in strength to betamethasone dipropionate. Both provide strong anti‑inflammatory effects, but mometasone has a slightly lower risk of skin atrophy when used intermittently. Choice between them depends on physician preference, formulation availability and patient response.

Mometason Glenmark should be stored at room temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, direct sunlight and extreme temperatures. Do not freeze the preparation, and ensure the container is tightly closed when not in use.

The medication is applied topically to the affected skin area. Clean and gently dry the skin, then spread a thin layer of the cream or ointment as directed by the prescriber, usually once or twice daily. Wash hands before and after application, and avoid contact with eyes, mouth or open wounds.

Serious risks include skin atrophy, telangiectasia and systemic effects such as hypothalamic‑pituitary‑adrenal axis suppression, especially with prolonged use over large areas. Signs of infection, severe burning or unusual bruising should prompt immediate medical evaluation and discontinuation of the product.

Mometason Glenmark is contraindicated in patients with known hypersensitivity to mometasone furoate or any excipients in the formulation. It should also be avoided on infected, ulcerated or severely damaged skin, and in individuals with untreated fungal, bacterial or viral skin infections unless directed by a physician.